Bryn Mawr Trust CO Embecta Corp. Transaction History
Bryn Mawr Trust CO
- $4.09 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in Embecta Corp. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 200 shares of EMBC stock, worth $2,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 209
4.31%
Holding current value
$2,910
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EMBC
# of Institutions
413Shares Held
56.7MCall Options Held
345KPut Options Held
68.7K-
Black Rock Inc. New York, NY9.19MShares$134 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO5.19MShares$75.5 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$67.2 Million0.0% of portfolio
-
River Road Asset Management, LLC3.25MShares$47.2 Million0.58% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.62MShares$38.1 Million0.69% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $842M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...